Investing.com - Danimer Scientific (NYSE: DNMR) reported second quarter EPS of $-0.38, $0.11 worse than the analyst estimate of $-0.27. Revenue for the quarter came in at $12.17M...
Investing.com - Danimer Scientific (NYSE: DNMR) reported first quarter EPS of $-0.36, $0.04 worse than the analyst estimate of $-0.32. Revenue for the quarter came in at $11.9M...
Investing.com - Danimer Scientific (NYSE: DNMR) reported first quarter EPS of $-0.26, $0.06 worse than the analyst estimate of $-0.21. Revenue for the quarter came in at $15.31M...
Investing.com - Danimer Scientific reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Danimer Scientific...
Danimer Scientific (DNMR) reported Q2 EPS of ($0.30), $0.06 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.7 million versus the consensus...
Danimer Scientific (DNMR) reported Q1 EPS of ($0.26), $0.03 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $14.7 million versus the consensus...
Danimer Scientific, Inc. (DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials,...